Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation  by Chen, P. et al.
FEBS Letters 583 (2009) 3478–3484journal homepage: www.FEBSLetters .orgFull characterization of PDX, a neuroprotectin/protectin D1 isomer, which
inhibits blood platelet aggregation
P. Chen a, B. Fenet b, S. Michaud a, N. Tomczyk c, E. Véricel a, M. Lagarde a, M. Guichardant a,*
aUniversité de Lyon, Inserm UMR 870, Insa-Lyon, RMND/IMBL, Inra 1235, 69621 Villeurbanne, France
bCCRMN-UCB-Lyon 1-ESCPE, France
cWaters Corporation – Atlas Park, Simonsway, Manchester M22 5PP, UK
a r t i c l e i n f o a b s t r a c tArticle history:
Received 23 July 2009
Revised 28 September 2009
Accepted 1 October 2009
Available online 8 October 2009
Edited by Veli-Pekka Lehto
Keywords:
Docosahexaenoic acid
15-Lipoxygenase
10,17-Dihydroxy-docosahexaenoic acid
Double lipoxygenation
Ion mobility separation0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.10.004
Abbreviations: BSTFA, N,O-Bis(trimethylsilyl)-triﬂu
ﬂuorobutyryl imidazole; DHA, docosahexaenoic acid;
* Corresponding author. Fax: +33 4 72 43 85 24.
E-mail address: michel.guichardant@insa-lyon.fr (Our study aimed to establish the complete structure of the main dihydroxy conjugated triene issued
from the lipoxygenation (soybean enzyme) of docosahexaenoic acid, named PDX, an isomer of pro-
tectin/neuroprotectin D1 (PD1/NPD1) described by Bazan and Serhan. NMR approaches and other
chemical characterization (e.g. GC–MS, HPLC and LC–MS/MS) indicated that PDX is 10(S),17(S)-dihy-
droxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid. The use of 18O2 and mass spectrometry showed
that PDX is a double lipoxygenation product. Its structure differs from PD1, with E,Z,E geometry
(PDX) instead of E,E,Z (PD1) and S conﬁguration at carbon 10 instead of R. PDX inhibits human blood
platelet aggregation at sub-micromolar concentrations.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Docosahexaenoic acid (DHA) oxygenated metabolism has been
investigated and increasing interest arose recently for dihydroxy-
DHA derivatives, especially neuroprotectin D1 (NPD1) described
in brain tissues by Bazan et al. [1,2]. Its structure has been estab-
lished by Serhan et al. as 10(R),17(S)-dihydroxy-docosahexa-
4Z,7Z,11E,13E,15Z,19Z-enoic acid [3–5] in T helper type 2-skewed
peripheral blood mononuclear cells as a 15/n6 lipoxygenase-
dependent product, and termed protectin D1 (PD1).
In mammalian cells NPD1/PD1 results from the 15-lipoxygen-
ation of DHA via an epoxidation mechanism [1] as already reported
for leukotriene B4 formation [6]. Resolvin D1 and PD1, as well as
mono-hydroxy-DHA products, were found to be produced by hu-
man whole blood and neutrophils [7], trout head, kidney [8], and
stroke-injured murine brain tissues [9]. In contrast, the PD1 iso-
mer, 10,17(S)-dihydroxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic
acid, reported by Butovich [10,11] could result from a double lipox-
ygenation mechanism, although this was not evidenced. Further-
more, the latter report did not state the conﬁguration of carbonchemical Societies. Published by E
roroacetamide; HFBI, hepta-
sLOX, soybean lipoxygenase
M. Guichardant).10 and did not claim any biological function. The goal of the pres-
ent study was to characterize the conﬁguration of carbon 10 and
geometry of the conjugated triene in PD1 isomer, called PDX, is-
sued from either the n6 lipoxygenation of either DHA, or 10(±)-
hydroxy-docosahexa-4Z,7Z,11E,13Z,16Z,19Z-enoic acid, or 17(S)-
hydroxy-docosahexa-4Z,7Z,10Z,13Z,15E,19Z-enoic acid. Character-
ization used homodecoupling NMR techniques and UPLC–MS/MS
with the Waters SYNAPT HDMS system and the integrated ion
mobility separation. Stereochemistry of carbon 10 was assessed
by HPLC and GC–MS approaches, and the mechanism of lipoxygen-
ation was determined by using 18O2. It is concluded that PDX is
10(S),17(S)-dihydroxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic
acid produced by double lipoxygenation of DHA.
Preliminary data regarding the inhibitory effect of PDX on plate-
let aggregation are also given.
2. Materials and methods
2.1. Reagents
DHA (22:6n-3), leukotriene B4, soybean lipoxygenase (sLOX, EC
1.13.11.12, Type 1-B, 131 000 units/mg solid) were purchased from
Sigma–Aldrich, 10(±)-hydroxy-docosahexa-4Z,7Z,11E,13Z,16Z,19Z-
enoic acid (10(±)-HDoHE), and 8(R)- and 8(S)-HETEs were fromlsevier B.V. All rights reserved.
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platinum oxide (PtO2) and N,O-Bis(trimethylsilyl)-triﬂuroroaceta-
mide (BSTFA) were products of Sigma–Aldrich, heptaﬂuorobutyryl
imidazole (HFBI) was from Interchim. Pestipur organic solvents
were from Carlo-Erba. All chemicals used were reagent grade or
with the highest quality available.
2.2. Chiral HPLC separation of 10(±)-HDoHE
Stereoisomers from methylesters of 10(±)-HDoHE were isolated
by isocratic chiral HPLC on a 4.6  250 mm Chiralcel OD-H column
hold at 25 C. The mobile phase was n-hexane/2-propanol (100:2,
v/v) pumped at a ﬂow rate of 1 mL/min. 10(R)-HDoHE and 10(S)-
HDoHE were detected at 235 nm and collected. Methylesters of
8(R)- and 8(S)-HETEs were used as corresponding homologs of
10(R)- and 10(S)-HDoHE, respectively.
2.3. Biosynthesis of 17(S)-hydroxy (HDoHE) and 10,17-dihydroxy
(diHDoHE) DHA derivatives, as well as 8,15-diHETEs from 8(R)- and
8(S)-HETE
Reactions were catalyzed by soybean lipoxygenase (sLOX) (type
1-B) in sodium-borate buffer under normal or 18O2 atmosphere
(PDX production from DHA). DHA was treated by sLOX, hydroper-
oxides were reduced by NaBH4, the incubate was acidiﬁed to pH 3,
and di- and monohydroxylated fatty acids were extracted using a
C18 solid-phase cartridge with 10 mL of ethanol. They were further
dried under a stream of nitrogen.
Similarly, 2 lM of either 17(S)-HDoHE (produced from DHA) or
10(R)-HDoHE, or 10(S)-HDoHE isolated by chiral HPLC as described
above, were treated by sLOX to generate 10,17-diHDoHE. 8,15-
diHETEs were obtained by the same way from commercial sources
of 8(R)- or 8(S)-HETE.Fig. 1. Typical RP-HPLC proﬁle of DHA derivatives. DHA was incubated with sLOX and li
(k = 235 nm); (B) dihydroxylated fatty acids (k = 270 nm).2.4. Puriﬁcation of monohydroxylated and dihydroxylated fatty acids
Mono- and dihydroxylated fatty acids were analyzed by reverse
phase high performance liquid chromatography (RP-HPLC) on a
Waters XBridge C18 column (4.6  250 mm, 3.5 lm) using a linear
solvent gradient (1 mL/min): A was a mixture of acetonitrile/water
acidiﬁed to pH 3 (10:90, v/v), and B was acetonitrile. Conjugated
diene monohydroxylated and conjugated triene dihydroxylated
fatty acids were detected using a diode array detector at 235 nm
and 270 nm, respectively, and collected separately.
2.5. GC–MS analysis of diHDoHE
DiHDoHE isolated by HPLC were hydrogenated using platinum
oxide, and derivatized into methyl esters and trimethylsilyl ethers.
Samples were then analyzed by GC–MS using electron impact
mode (EI) to localize the hydroxyl groups in the fatty chain.
2.6. Nuclear magnetic resonance (NMR) of PDX
NMR spectra were acquired on a BRUKER drx500 spectrometer
equipped with a 5 mm TXI probe. Experiments were driven at
25 C on 2 mg of samples dissolved in 450 lL of CD3OD.
2.7. UPLC–MS of 10,17-diHDoHE and ion mobility
Dihydroxylated-DHA isomers were analyzed on the Waters
SYNAPTTM HDMSTM system in MS mode coupled directly to the
Acquity UPLC with a BEHTM-C18 1.7 lm, 1.0 mm  100 mm col-
umn. The separation was performed at 40 C at a ﬂow rate of
0.25 mL/min using a mobile phase system which consisted of ace-
tonitrile/water (containing 0.1% of formic acid) that was run as a
linear gradient to reach 100% acetonitrile (containing 0.1% ofpid extract was analyzed by reverse phase HPLC: (A) Monohydroxylated fatty acids
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The ion mobility of PDX and Isomer 1 (obtained from the lipox-
ygenation of 10(S)-HDoHE) were measured on the SYNAPT HDMS
system in HDMS mode. All samples were infused at a ﬂow rate
of 10 lL/min and ionized using electrospray ionization-mass spec-
trometry (ESI). ESI-MS/MS was performed on the M+Na adduct and
mobility separations were performed with nitrogen admitted to
ion mobility cell at a pressure of 0.5 mbar. Data extraction and
analysis were performed with MassLynxTM and DriftscopeTM
software.
3. Results and discussion
3.1. Metabolites of DHA obtained after soybean 15-lipoxygenase
(sLOX)treatment
DHAwas a good substrate for sLOX and led to a main compound
eluted at 51.6 min (Fig. 1A). This compound was identiﬁed as
17(S)-HDoHE since it had the same retention time as commercially
available 17(R)-HDoHE on reverse phase HPLC, but separated from
it by chiral HPLC, both compounds having the same UV spectrum
with kmax = 235 nm. In addition, a main product called PDX, eluted
at 35.4 min, and was detected at 270 nm (Fig. 1B), as well as ﬁveFig. 2. Mass-spectrum of the Me-TMS derivative of the hydrogenated PDX syminor compounds, all with a conjugated triene structure according
to their UV spectra (Fig. 1B). The minor conjugated trienes had
shorter retention times compared to PDX, but their amounts were
much too low (the whole ﬁve compounds represented less than 5%
of the amount of PDX) to allow their characterization.
The UV spectrum of PDX (Fig. 1B inset) showed a maximum
absorption at k = 270 nm with two smooth shoulder peaks at
k = 260 nm and k = 280 nm indicating the presence of a conjugated
triene. Moreover, the left shoulder peak was higher than the right
shoulder one suggesting that the triene geometry could likely be
E,Z,E, as observed with 8(S),15(S)-di-HETE and 5(S),12(S)-diHETE
which have the same triene geometry (results not shown). UV
spectra of these compounds differ from compounds with a Z,E,E
conﬁguration such as leukotriene B4 (LTB4) and 12-epi-LTB4, for
which both right and left sharp shoulder peaks have nearly the
same height (results not shown). In our conditions, the yield con-
version rate of DHA by sLOX was estimated at 10% for the monohy-
droxy derivative and 3% for the dihydroxy one (PDX).
3.2. Localization by GC–MS of hydroxy groups on the chain
For this purpose, PDX was derivatized as described in Section 2.
GC–MS spectrum of the hydrogenated PDX derivative showed
characteristic ions at m/z: 515 (M-15, loss of CH3), 459 (M-71 lossnthesized from DHA by sLOX under normal (A) or 18O2 (B) atmosphere.
Fig. 3. Typical RP-HPLC proﬁle of dihydroxylated fatty acids issued from 8(S)- and 8(R)-diHETE, and from 17-HDoHE stereoisomers (R and S): (A) the upper tracing shows
8(S),15(S)-diHETE and 8(R),15(S)-diHETE synthesized from 8(S)- and 8(R)-diHETE treated by sLOX; (B) typical RP-HPLC proﬁle of 10(S),17(S)-diHDoHE and 10(R),17(S)-
diHDoHE synthesized from 10(S)- and 10(R)-HDoHE separated from 10(±)-HDoHE; (C) typical RP-HPLC proﬁle of 10(S),17(S)-diHDoHE and 10(R),17(S)-diHDoHE plus PDX
synthesized from DHA.
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CH2–(CH2)7–COOCH3), 273 (basepeak,Me3SiO+–CH2–(CH2)8–COOCH3),
173 (Me3SiO+–CH2–(CH2)4–CH3) and 73 (SiMe3) (Fig. 2A). PDX syn-
thesized under 18O2 atmosphere revealed a shift of the fragments
ion mass of 2 or 4 (Fig. 2B), indicating the insertion of 18O at both
carbons 10 and 17 (m/z at 519 and 463 instead of 515 and 459,
and 371, 275, 175 and 131 instead of 369, 273, 173 and 129).
3.3. Determination of carbon 10 stereochemistry
If the stereochemistry of carbon 17 is S according to the well
known properties of sLOX [12], that of carbon 10 remained to be
determined. For this purpose, 17(S)-HDoHE prepared from DHA
treated by sLOX, and 10(S)- and 10(R)-HDoHE separated by chiral
chromatography from 10(±)-HDoHE, were incubated separately
with sLOX followed by hydroperoxide reduction. Two diastereo-
isomers were eluted by HPLC (Fig. 3B) at 36.7 and 37.1 min. The
ﬁrst peak was attributed to 10(S),17(S)-diHDoHE and the second
to 10(S),17(R)-diHDoHE, according to the separation (Fig. 3A) of
8(S),15(S)- and 8(R),15(S)-diHETEs synthesized from 8(S)-HETE
and 8(R)-HETE, respectively [13]. Moreover, the former diHETE
also co-eluted with commercial 8(S),15(S)-diHETE. In addition,
the lipoxygenation of 17(S)-HDoHE led to a dihydroxy derivative
that co-eluted with 10(S),17(S)-diHDoHE (not shown).
Finally, PDX synthesized from DHA, co-eluted with 10(S),17(S)-
diHDoHE issued from 10(S)-HDoHE (Fig. 3C) whereas 10(R),17(S)-
diHDoHE from 10(R)-HDoHE was eluted 0.5 min later, as shown inFig. 3B, which indicates that PDX has the S stereochemistry at car-
bon 10, and the same E,Z,E geometry of the conjugated triene, as
already described for AA dioxygenation [14].
The complete structure was also conﬁrmed by using a new
UPLC–MS/MS system including an ion mobility interface which is
able to discriminate between different isotopologues which differ
in their structure. For this purpose, 10(S),17(S)-diHDoHE and PDX
were analyzed by UPLC using electrospray ionization as described
in Section 2. The mass spectrum of PDX (Fig. 4A) was superimpos-
able to that of 10(S),17(S)-diHDoHE, with the same main ion atm/z
383 corresponding to the sodium adduct. In addition, the HDMS
infusion data of PDX and 10(S),17(S)-diHDoHE, where the M+Na
was isolated in the quadrupole, showed that they have identical
drift time which indicates they have the same collisional cross sec-
tional areas. This is shown by the mobilograms of PDX and
10(S),17(S)-diHDoHE (Fig. 4B) which are fully superimposable ex-
cept for a small contaminant detected in 10(S),17(S)-diHDoHE.
This is again in agreement with PDX being 10(S),17(S)-dihy-
droxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid.
Overall, these results are in favour of a double lipoxygenation
with a S,S conﬁguration as expected according to similar mecha-
nism which has already been reported for some diHETEs from ara-
chidonic acid. This is valid for 5(S),12(S)-dihydroxy-
eicosatetraenoic acid (5(S),12(S)-diHETE), which results from the
oxygenation of 12(S)-hydroxy-eicosatetraenoic acid (12(S)-HETE)
by 5-lipoxygenase, or 5(S)-HETE by 12-lipoxygenase [15–17], and
for 5(S),15(S)-diHETE through 5- and 15-lipoxygenases [18]. This
Fig. 4. Analysis of PDX by UPLC–MS/MS using an ion mobility interface: (A) full LC–MS/MS spectra of Isomer 1 and PDX; (B) mass extracted mobilograms of Isomer 1 and PDX
from full scan MS/MS.
Fig. 5. Sequential attribution of PDX with IPAP HSQC–TOCSY. The ﬁgure is the overlay of two matrices: the sum of in-phase IP HSQC–TOCSY and anti-phase AP HSQC–TOCSY
experiment, and the difference of the two matrices. Empty regions are cut to increase the resolution drawing. Ns = 16, time domain td2 = 2048 td1 = 2048, processing domain
si2 = 2048, si1 = 2048 with linear prediction.
3482 P. Chen et al. / FEBS Letters 583 (2009) 3478–3484hypothesis was validated by using 18O2 since both hydroxyl groups
at carbon 10 and 17 were labelled. According to these results,which complete and ﬁt with previous data from Butovich, we can
deﬁnitely conclude that 15-soybean lipoxygenase produces PDX
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described 10,17(S)-docosatriene by Hong et al. [7], further named
PD1.
3.4. Determination by different NMR techniques of the PDX conjugated
triene geometry
Taking into account that the stereochemistry of carbon 10 has
not yet been assigned, it was important to verify the geometry of
double bounds, provided that PD1 has an R conﬁguration at carbon
10, with a E,E,Z triene as reported by Serhan et al. [3]. Sequential
attribution of protons and carbon atoms via a high resolution
HSQC–TOCSY experiment (starting from each edge of the mole-
cule), and high resolution 2D matrix (Fig. 5) allow a good sequen-
tial identiﬁcation of spin systems. 11–12–13 and 14–15–16 spin
systems at the center of the molecule were quite indistinguishable
(same proton and same carbon chemical shifts), which in fact con-
ﬁrms the symmetrical structure of the triene segment. We used a
modiﬁed HSQC–TOCSY experiment (IPAP hsqc-gpsp) [19] to in-
crease resolution for AB spin systems, and a 30 ms mixing time
to get more information from those very near cross peaks. At this
stage, the attribution of all protons and carbons conﬁrms the re-
sults of previous works of Butovich [10]. However, collected NMR
data presented in Table 1 showed that the acidic carbon is missing
in the 13C spectrum, and remains not determined.
In a second step, we measured proton J coupling constants in
the conjugated triene. The easiest part was J11,12 and J15,16, because
of the AX character of spin system. A simple 1D proton spectrum
with multisite homodecoupling [20] of H13–H14 and H10–H17
led to J11,12 = J15,16 = 15 Hz (Fig. 6A) demonstrating the E character
of these two double bonds. At the end, the measurement of J13,14
was more difﬁcult to get because of second order effects between
H13 and H14, and superimposition of carbon signals. However, we
succeeded to get a good measurement by the SAPHIR method
[21] (Fig. 6B). The heart of the method was based on the asymme-
try introduced in the AB system by the diluted carbon 13 isotope.
Considering a 2D HSQC experiment acquired without 13C decou-
pling, the response of the couple H13–13C13 was split in a doublet
with JCH = 158 Hz, whereas the H14–12C14 neighbor was at the cen-
ter of this doublet, cancelling second order effects. In addition, theTable 1
1H and 13C measured chemical shifts and proton coupling constants of PDX in CD3OD
at 25 C. For AB spin systems, the values were reﬁned by spectral simulation.
Atom number Proton Carbon (ppm)
d (ppm) Coupling constant (Hz)
1 N.D.
2 2.347 m 34.298
3 2.39 m 23.022
4 5.406 m 128.300
5 5.409 m 129.047
6 2.822 t, J(6,5) = J(6,7) = 5.35 25.704
7 5.467 m 130.009
8 5.461 m 125.516
9 2.4 m, J(9,10) = 6.5 35.350
10 4.198 J(10,11) = 6.3, J(10,12) = 1.3 72.043
11 5.757 J(11,12) = 15 137.127
12 6.747 J(12,13) = 11, J(12,14) = 0.8 125.476
13 5.991 J(13,14) = 11, J(13,15) = 0.8 128.966
14 5.995 J(14,15) = 11 128.985
15 6.741 J(15,16) = 15, J(15,17) = 1.3 125.476
16 5.744 J(16,17) = 6.3 137.066
17 4.174 J(17,18) = 6.5 72.142
18 2.320 m 35.210
19 5.387 m 124.446
20 5.493 m 133.674
21 1.2 J(21,22) = 7.05 20.667
22 0.983 7.5 13.518
Fig. 6. NMR techniques applied to PDX to achieve the double bond conﬁguration:
(A) Zooming of H11 and H16 signals: bottom: normal proton spectrum; top: with
simultaneously homodecoupling of H13–H14 and H10–H17. The simultaneous two
sites decoupling driven by frequency modulation of homodecoupling signal
(standard Bruker sequence zghc) were the shape pulse used in the decoupling
sequence, tuned to irradiate the wanted frequencies. (B) SAPHIR–HSQC method for
measuring J coupling constant in the AB spin system H13–H14. HSQC without
carbon decoupling was used during acquisition and simultaneous homodecoupling
of H12–H15 and H11–H16. The measured coupling constant was J13,14 = 11 Hz; (C)
Comparison between the simulated spectrum (upper window) and the experimen-
tal spectrum (lower window). The spectrum of the central part of the molecule
containing the triene motif with the two hydroxyl groups was simulated with the
BRUKER DAISY spin simulator (upper window) and compared to the acquired
spectrum (lower window). Non-informative region was hidden with the cutting
tool of MestReNova processing software.homodecoupling of all other coupled protons during acquisition
led to simple couple of proton doublets separated by JCH. The mea-
surement of JH13—H14 ¼ 11 Hz gave the evidence that this double
bond was in a Z geometry.
As a conﬁrmation, in a last step, we simulated (Fig. 6C) the spec-
trum of the central part of the molecule with the BRUKER DAISY
Fig. 7. Dose-dependent inhibition of platelet aggregation by PDX. Human isolated
blood platelet suspensions were incubated with different concentrations of PDX
(0.3–10 lM). Aggregation was triggered by collagen and monitored for 4 min.
3484 P. Chen et al. / FEBS Letters 583 (2009) 3478–3484spin simulator. Ten spins were taken into account, and the result
was very close to the acquired spectrum, conﬁrming the determi-
nation. This NMR study conﬁrms that the geometry of the conju-
gated triene in PDX is 11E,13Z,15E.
3.5. Inhibition of platelet aggregation by PDX
PDX incubated with platelet suspension at different concentra-
tions ranged from 0.3 lM to 10 lM inhibited collagen-induced
platelet aggregation in a dose-dependent manner (Fig. 7).
Twenty-ﬁve percent and seventy-ﬁve percent inhibition were ob-
served at 0.3 lM and 1 lM of PDX, respectively.
4. Conclusions
We conclude from the present data that the main dihydroxyl-
ated compound issued from the 15-lipoxygenation of DHA by the
soybean enzyme is PDX. Its structure, 10(S),17(S)-dihydroxy-doco-
sahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid, differs from PD1 de-
scribed as 10(R),17(S)-dihydroxy-docosahexa-4Z,7Z,11E,13E,15Z,
19Z-enoic acid [3]. Moreover, PDX exhibits interesting inhibition
of human blood platelet aggregation.
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